References
- Thompson MJ, Ninis N, Perera R et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet367(9508), 397–403 (2006).
- Pollard AJ. Global epidemiology of meningococcal disease and vaccine efficacy. Pediatr. Infect. Dis. J.23(12 Suppl.), S274–S279 (2004).
- Kaplan SL, Schutze GE, Leake JA et al. Multicenter surveillance of invasive meningococcal infections in children. Pediatrics118(4), e979–e984 (2006).
- Sharip A, Sorvillo F, Redelings MD, Mascola L, Wise M, Nguyen DM. Population-based analysis of meningococcal disease mortality in the United States: 1990–2002. Pediatr. Infect. Dis. J.25(3), 191–194 (2006).
- Pollard AJ, Scheifele D. Meningococcal disease and vaccination in North America. J. Paediatr. Child Health37(5), S20–S27 (2001).
- Pace D, Pollard AJ. Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines. Arch. Dis. Child92(10), 909–915 (2007).
- De Wals P. Meningococcal C vaccines: the Canadian experience. Pediatr. Infect. Dis. J.23(12 Suppl.), S280–S284 (2004).
- Balmer P, Borrow R, Miller E. Impact of meningococcal C conjugate vaccine in the UK. J. Med. Microbiol.51(9), 717–722 (2002).
- Snape MD, Perrett KP, Ford KJ et al. Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial. JAMA299(2), 173–184 (2008).
- Harrison LH. A multivalent conjugate vaccine for prevention of meningococcal disease in infants. JAMA299(2), 217–219 (2008).
- O’Hallahan J, Lennon D, Oster P. The strategy to control New Zealand’s epidemic of group B meningococcal disease. Pediatr. Infect. Dis. J.23(12 Suppl.), S293–S298 (2004).
- Rennels M, King J Jr, Ryall R, Papa T, Froeschle J. Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meninogococcal polysaccharide diphtheria toxoid conjugate vaccine in infants. Pediatr. Infect. Dis. J.23(5), 429–435 (2004).
- American Academy of Pediatrics Committee on Infectious Diseases. Prevention and control of meningococcal disease: recommendations for use of meningococcal vaccines in pediatric patients. Pediatrics116(2), 496–505 (2005).